Jude Children's Research Hospital / Hospital of Philadelphia / A.I. duPont Hospital / Stable Disease / Cancer Institute Australia / Duke University Medical Center / /
IndustryTerm
Cancer Therapy / /
MedicalCondition
tumor / lymphoblastic leukemia / tumors / Glioblastoma Neuroblastoma Neuroblastoma Neuroblastoma Neuroblastoma ALL ALL ALL ALL ALL ALL AML ALCL NHL rIC50 / neuroblastomas / solid tumor / childhood cancers / solid tumors / Progressive Disease / median relative tumor / et al. Pediatr Blood Cancer / hematologic malignancies / osteosarcoma / neuroblastoma / PPTP solid tumor / individual solid tumor / Stable Disease / perpendicular tumor / evaluable solid tumor / rhabdomyosarcoma xenografts / several pediatric cancers / SC tumors / glioblastoma / individual tumor / rhabdomyosarcoma / /
MedicalTreatment
chemotherapy / Cancer Therapy / /
Movie
A.I. / /
OperatingSystem
OS-2 / OS-9 / /
Organization
Texas Tech University Health Sciences Center / A.I. duPont Hospital for Children / Research Hospital / Hospital of Philadelphia / SD CR / St. Jude Children's Research Hospital / Cancer Institute Australia / Duke University Medical Center / /
Person
Richard Lock / E. Anders Kolb / Stephen T. Keir / Min H. Kang / Peter J. Houghton / Catherine A. Billups / John M. Maris / C. Patrick Reynolds / Like Kinase (Plk) / Malcolm A. Smith / Richard Gorlick / /
Abstract: LB-317 Pediatric Preclinical Testing Program (PPTP) Evaluation of Volasertib (BI 6727), a Polo-Like Kinase (Plk) Inhibitor